Thomas J. Lamb Law Blog

Reports Of Male Breast Cancer Associated With The Use Of Propecia And Proscar

Thursday, August 18, 2011 by Thomas J. Lamb

Reports Of Male Breast Cancer Associated With The Use Of Propecia And Proscar Recent Label Change For These Drugs Made In Canada But Not In U.S., Yethttp://www.drug-injury.com/druginjurycom/2011/08/proscar-propecia-male-breast-cancer-finasteride- side-effect-warning-health-canada-merck.html... Read More
Posted at 09:51 AM  |  PERMALINK
Topic: Drug and Medical Device Litigation

Increased Risk Of Bladder Cancer Warning Added To Actos Label By Takeda Announced In August 2011

Wednesday, August 10, 2011 by Thomas J. Lamb

Increased Risk Of Bladder Cancer Warning Added To Actos Label By Takeda Announced In August 2011European Drug Regulator EMA Recommended New Actos Contra-Indications And Warnings In July 2011http://www.drug-injury.com/druginjurycom/2011/08/actos-bladder-cancer-warning-fda-drug-safety-ta keda-label-change-2011.html... Read More
Posted at 09:55 AM  |  PERMALINK
Topic: Drug and Medical Device Litigation

YAZ / Yasmin / Ocella / Beyaz / Safyral: Drug Safety Regulators Focus On Blood Clot Side Effects

Wednesday, August 3, 2011 by Thomas J. Lamb

YAZ / Yasmin / Ocella / Beyaz / Safyral: Drug Safety Regulators Focus On Blood Clot Side EffectsEMA Orders New Warning About Risk Of Venous Thromboembolism, While FDA And Health Canada Begin Safety Reviewhttp://www.drug-injury.com/druginjurycom/2011/07/drug-safety-reviews-drospirenone-drsp-birth-c ontrol-pills-ema-fda-canada.html... Read More
Posted at 10:57 AM  |  PERMALINK
Topic: Drug and Medical Device Litigation

Multaq Cardiovascular Deaths Overshadow Earlier Liver Injury Concerns For Drug Regulators

Wednesday, July 27, 2011 by Thomas J. Lamb

Multaq Cardiovascular Deaths Overshadow Earlier Liver Injury Concerns For Drug RegulatorsFDA Now Looking At Two-Fold Increase In CV Deaths, Strokes, And Heart Failure Hospitalizations From PALLAS Study Data http://www.drug-injury.com/druginjurycom/2011/07/multaq-deaths-cardiovascular-heart-failur e-stroke-fda-safety-review-ema-health-canada-pallas.html... Read More
Posted at 09:52 AM  |  PERMALINK
Topic: Drug and Medical Device Litigation

Sanofi Heart Medication Multaq Has Constantly Been On FDA's Radar During 2010 And 2011

Friday, July 22, 2011 by Thomas J. Lamb

Sanofi Heart Medication Multaq Has Constantly Been On FDA's Radar During 2010 And 2011Liver Failure, Renal Impairment, And Cardiovascular Problems Cited As Potential Signals Of Risk Involving Multaqhttp://www.drug-injury.com/druginjurycom/2011/07/multaq-safety-signals-fda-watch-list-kidney-f ailure-liver-heart-side-effects-risks.html... Read More
Posted at 09:58 AM  |  PERMALINK
Topic: Drug and Medical Device Litigation

Multaq Update: European Safety Review Expanded To Cardiovascular Side Effects Risk In July 2011

Wednesday, July 20, 2011 by Thomas J. Lamb

Multaq Update: European Safety Review Expanded To Cardiovascular Side Effects Risk In July 2011EMA And FDA Already Had Sanofi Issue A "Dear Doctor" Letter About Liver Failure In January 2011http://www.drug-injury.com/druginjurycom/2011/07/dronedarone-sanofi-trial-heart-problems-multaq- ema-fda-safety-study-liver-injury.html... Read More
Posted at 09:58 AM  |  PERMALINK
Topic: Drug and Medical Device Litigation

Chantix Anti-Smoking Pill: How Significant Is The Heart Risk; Should Chantix Be Recalled

Thursday, July 7, 2011 by Thomas J. Lamb

Chantix Anti-Smoking Pill: How Significant Is The Heart Risk; Should Chantix Be RecalledCanadian Medical Journal Article Suggests That The June 2011 Label Change By FDA And Pfizer Is Not Sufficient Measurehttp://www.drug-injury.com/druginjurycom/2011/07/chantix-heart-attack-risks-cardiovascular-si de-effects-varenicline-smoking-addiction-drug-safety.html... Read More
Posted at 09:42 AM  |  PERMALINK
Topic: Drug and Medical Device Litigation

Actos And Avandia Use Associated With Diabetic Macular Edema, Which Can Lead To Blindness

Wednesday, June 29, 2011 by Thomas J. Lamb

Actos And Avandia Use Associated With Diabetic Macular Edema, Which Can Lead To BlindnessNew UK Study Found Three To Six Times Increased Risk Of Developing This Retinal Eye Disease Side Effecthttp://www.drug-injury.com/druginjurycom/2011/06/avandia-actos-side-effect-eye-disease-diabeti c-macular-edema-dme-blindness.html... Read More
Posted at 10:48 AM  |  PERMALINK
Topic: Drug and Medical Device Litigation

Actos-Related Bladder Cancer: June 2011 Review Of Regulatory Actions And Safety Warnings

Tuesday, June 21, 2011 by Thomas J. Lamb

Actos-Related Bladder Cancer: June 2011 Review Of Regulatory Actions And Safety WarningsFDA And Health Canada Warn About Increased Risk, While France And Germany Suspend Actos Saleshttp://www.drug-injury.com/druginjurycom/2011/06/actos-bladder-cancer-increased-risk-fda-warnin g-drug-recall-europe-ema-health-canada.html... Read More
Posted at 10:19 AM  |  PERMALINK
Topic: Drug and Medical Device Litigation

June 2011 FDA Warning About 80 mg Dose Of Zocor, Simvastatin, And Vytorin Cholesterol Medications

Tuesday, June 14, 2011 by Thomas J. Lamb

June 2011 FDA Warning About 80 mg Dose Of Zocor, Simvastatin, And Vytorin Cholesterol MedicationsHighest Simvastatin Dosage Linked To Potentially Fatal Rhabdomyolysis Muscle Injury And Kidney Failurehttp://www.drug-injury.com/druginjurycom/2011/06/fda-warning-80mg-simvastatin-zocor-rhabdomyo lysis-rhabdo-muscle-injury-kidney-failure.html... Read More
Posted at 10:19 AM  |  PERMALINK
Topic: Drug and Medical Device Litigation
« previous page   (Page 2 of 22, totaling 220 entries)   next page »
Lawyers.com Blog

Lawyers.comSM Blog

Get an inside view of
Lawyers.com

About Me

Photo of Thomas J. Lamb

Blog Topics

Bloggers

Thomas J. Lamb (220)

Archives

Recent...